InsiderTrades

Form 4 for TMDX TransMedics Group, Inc.

Accepted 2022-11-23 00:00:00 ET · period of report 2022-11-22 · accession 0000899243-22-036935 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-11-23 2022-11-22+ TMDX Lovell Stephanie Dir S - Sale+OE $58.80 -10.6K 0 -100% -$620.7K
DM 2022-11-23 2022-11-22+ TMDX Lovell Stephanie Dir M - OptEx $45.57 +10.6K 3,800 New +$481.1K
DM 2022-11-23 2022-11-22+ TMDX Lovell Stephanie Dir M - OptEx $0.00 -10.6K 14.2K -43% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-11-23 S D 5,657 $59.50 0 D — —
2 Common Common Stock 2022-11-23 M A 5,657 $47.82 5,657 D — —
3 Common Common Stock 2022-11-22 S D 1,100 $58.04 0 D — —
4 Common Common Stock 2022-11-22 M A 1,100 $26.26 1,100 D — —
5 Common Common Stock 2022-11-22 S D 3,800 $57.97 0 D — —
6 Common Common Stock 2022-11-22 M A 3,800 $47.82 3,800 D — —
7 Derivative Stock Option (Right to Buy) 2022-11-23 M D 5,657 $0.00 8,543 D $47.82 · — to 2031-03-22 5,657 Common Stock (F1) The option vested as to one-third of the shares subject to the option on March 22, 2022 and vests in equal monthly installments as to the remainder of the shares for two years thereafter.
8 Derivative Stock Option (Right to Buy) 2022-11-22 M D 1,100 $0.00 1,150 D $26.26 · — to 2031-05-27 1,100 Common Stock (F1) The option vested as to one-third of the shares subject to the option on March 22, 2022 and vests in equal monthly installments as to the remainder of the shares for two years thereafter.
9 Derivative Stock Option (Right to Buy) 2022-11-22 M D 3,800 $0.00 14,200 D $47.82 · — to 2031-03-22 3,800 Common Stock (F1) The option vested as to one-third of the shares subject to the option on March 22, 2022 and vests in equal monthly installments as to the remainder of the shares for two years thereafter.